Back to Search
ANDREW SANDLER, M.D.
M.D.
Specialist
NPI: 1598072555Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
00035439(WA)
Research & Publications (20)
A "plastic" sutureless abdominal wall closure in gastroschisis.
PMID 15137009·J Pediatr Surg·2004
8-other
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
PMID 12543793·Cancer Res·2003
7-preclinical
The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma.
PMID 11877677·J Pediatr Surg·2002
4-observational
Nonanatomic hepatic resection with a pledgetted suturing technique.
PMID 11150467·J Pediatr Surg·2001
5-case
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
PMID 10623702·J Clin Oncol·2000
3-trial
Angiogenesis in the treatment of non-small cell lung cancer.
PMID 19349490·Proc Am Thorac Soc·2009
6-review
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
PMID 19597027·J Clin Oncol·2009
3-trial
Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.
PMID 19362948·Clin Lung Cancer·2009
6-review
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
PMID 19404213·J Thorac Oncol·2009
3-trial
The right to nutrition and hydration: a need for vigilance.
PMID 19489668·Intellect Dev Disabil·2009
8-other
Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy.
PMID 19289368·Clin Lung Cancer·2009
6-review
The role of adenosine in hypercarbic hyperemia: in vivo and in vitro studies in adenosine 2(A) receptor knockout and wild-type mice.
PMID 19199466·J Neurosurg·2009
7-preclinical
Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.
PMID 19255315·J Clin Oncol·2009
8-other
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
PMID 19224857·J Clin Oncol·2009
3-trial
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.
PMID 19240650·J Thorac Oncol·2009
3-trial
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma.
PMID 19186194·Adv Drug Deliv Rev·2009
6-review
Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.
PMID 19671872·Clin Cancer Res·2009
6-review
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
PMID 18719913·Cancer Immunol Immunother·2009
7-preclinical
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
PMID 19276291·Clin Cancer Res·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1812 TENTH AVENUE EAST
SEATTLE, WA 98102 - Phone
- (206) 328-6558
Quick Facts
- NPI
- 1598072555
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile